# OnCo record fumanba-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/fumanba-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "fumanba-1", "NCT05066646" ;
  schema:name "FUMANBA-1"@en ;
  schema:description "The single-arm trial that won eque-cel its approval in China, with almost every patient responding and most reaching deep remissions."@en ;
  schema:url <https://onco.cc/trials/fumanba-1/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05066646>, <https://doi.org/10.1001/jamaoncol.2024.4879> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "1/2" ;
  schema:startDate "2020-04-01" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:drugs <https://onco.cc/drugs/equecabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/iaso-bio/>, <https://onco.cc/companies/innovent/> ;
  onco:institutions <https://onco.cc/institutions/tongji-hospital-wuhan/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-li-jama-oncol/> .